Mitchell Blutt, MD
Managing Partner & Co-Founder

Email Mitchell

Mitchell Blutt – Managing Partner & Co-Founder

Mitchell Blutt, MD is a Managing Partner and Co-Founder of Consonance Capital Partners and CEO of Consonance Capital and Consonance Capital Management. Prior to founding Consonance Capital, he was Executive Partner at JPMP from 1992 until 2004. In addition to his general management responsibilities across JPMP, Mitchell founded and led the Healthcare Group for nearly 18 years. He was one of the earliest employees at Chemical Venture Partners, the predecessor to JPMP, joining in 1987. Mitchell has served or currently serves on numerous boards, including ASC Network, Cardinal Health, Cooper Holding, DJO, Fisher Scientific, General Medical, Hanger Orthopedic Group, Medical Arts Press, Tenax, Thermoscan, and Whitmire Distribution.

Mitchell served on the Board of Trustees of Penn Medicine, the Health System of the University of Pennsylvania from 2002 to 2012, the Board of Trustees of the University of Pennsylvania from 1998 to 2008, the Board of Trustees of the Brearley School, and the Board of the Michael J. Fox Foundation for Parkinson’s Research. Mitchell is a Clinical Assistant Professor of Medicine at Weill Cornell Medical College and is on the New York Weill Cornell Council and the Dean’s Council of the Weill Cornell Medical College. He holds BA, MD, and MBA degrees from the University of Pennsylvania.

Benjamin Edmands
Managing Partner & Co-Founder

Email Benjamin

Benjamin Edmands – Managing Partner & Co-Founder

Benjamin Edmands is a Managing Partner and Co-Founder of Consonance Capital Partners. Prior to founding CCP, he was a Managing Director at JPMP, where he co-led the Healthcare Group. Benjamin joined JPMP in 1993 and served on numerous boards, including Big Rock, CareMore, DJO, LHP Hospital Group, MedQuest, National Surgical Care, and Warner Chilcott, Inc. He also serves on the board of Mount Sinai’s Children’s Environmental Health Center and is on the Executive Council of the Harvard School of Public Health. Benjamin holds a BA from Colgate University and an MBA from Columbia Business School.

Stephen McKenna
Managing Partner & Co-Founder

Email Stephen

Stephen McKenna – Managing Partner & Co-Founder

Stephen McKenna is a Managing Partner and Co-Founder of Consonance Capital Partners. Prior to founding CCP, he was a Managing Director at JPMP, where he focused on making growth equity and buyout investments. Stephen served on numerous boards, including Generac Power Systems, Jetro Holdings, National Waterworks, and PQ Corp. Prior to joining JPMP in early 2000, Stephen worked in the Investment Banking Group of Morgan Stanley and the Mergers & Acquisitions Group of JPMorgan. Stephen holds a BA from Dartmouth College and an MBA from the University of Chicago Booth School of Business.

Nancy-Ann DeParle
Partner & Co-Founder

Nancy-Ann DeParle – Partner and Co-Founder

Nancy-Ann DeParle is a Partner and Co-Founder of Consonance Capital Partners. Prior to CCP, she was Assistant to the President and Deputy Chief of Staff for Policy in the Obama White House from 2011-2013, and served as Counselor to the President and Director of the White House Office of Health Reform from 2009-2011. Before joining the White House, DeParle was a Senior Advisor and Managing Director at JPMP from 2001 to 2009, where she was a member of the Healthcare Group and served on numerous boards, including CareMore, LHP Hospital Group, and MedQuest. In addition, she was a Commissioner of MedPAC, the advisory board to Congress on Medicare policy matters, for six years. From 1997 to 2000, she served as the Administrator of the Centers for Medicare and Medicaid Services (CMS). DeParle was also a Senior Fellow and Adjunct Professor of Health Systems Management at The Wharton School of the University of Pennsylvania and a trustee or director of several corporate and non-profit boards including Accredo, Cerner, DaVita, Guidant, Medco Health, Triad Hospitals, Boston Scientific and the Robert Wood Johnson Foundation.

DeParle currently serves on the board of directors of Enclara, HCA Holdings, Inc. (NYSE: HCA) and CVS Health (NYSE: CVS); she also served on the board of CCP’s portfolio company KEPRO prior to its sale. She received a B.A. from the University of Tennessee and a J.D. from Harvard Law School. She also received a B.A. and M.A. in Politics and Economics from Balliol College of Oxford University, where she was a Rhodes Scholar.

Sean Breen
Principal

Email Sean

Sean Breen – Vice President

Sean Breen joined Consonance Capital Partners in 2012 as a Vice President. Prior to joining CCP, he was a Senior Associate at JPMP, where he focused on making growth equity and buyout investments in the healthcare, consumer, retail and information services industries. Prior to joining JPMP in 2008, Sean worked in the Global Leveraged Finance Group at Lehman Brothers in the New York office. He graduated from Middlebury College with a BA in Economics and History.

Javier Starkand
Principal

Email Javier

Javier Starkand – Vice President

Javier Starkand joined Consonance Capital Partners in 2012 as a Vice President. Prior to joining CCP, Javier was an investment professional in the Healthcare group at Warburg Pincus. Prior to business school, he worked as an Associate at JPMP before co-founding The Spirus Group, a New York-based venture development firm. He also worked in the Technology M&A Group at Morgan Stanley. Javier holds an MBA from The Stanford Graduate School of Business. Additionally, he holds a BSE in finance from The Wharton School and a BA from the University of Pennsylvania, College of Arts & Sciences.

Sapna Tejwani Jethwa
Vice President

Email Sapna

Sapna Tejwani Jethwa – Vice President

Sapna Tejwani Jethwa joined Consonance Capital Partners in 2011 as a Vice President. Prior to joining CCP, she held positions at Bessemer Venture Partners and in JPMorgan’s Healthcare Investment Banking Group. Prior to business school, she was a Project Leader at The Monitor Group where she predominantly served healthcare clients on a range of corporate strategy and corporate finance-related issues. Sapna holds an MBA from The Wharton School and is a graduate of the Healthcare Management Program. Additionally, she holds a BAS in biomedical science from the University of Pennsylvania, School of Engineering & Applied Sciences and a BSE in finance from The Wharton School.

Alex Flick
Senior Associate

Email Alex

Alex Flick

Alex Flick joined Consonance Capital Partners in 2015 as an Associate. Prior to joining CCP, he was an analyst in the Healthcare Investment Banking group at Jefferies. Alex holds a B.S. in Management with concentrations in finance and accounting from the Carroll School of Management at Boston College.

Michael Zhuang
Associate

Michael Zhuang - Associate

Michael Zhuang joined Consonance Capital Partners in 2017 as an Associate. Prior to joining CCP, he was an Investment Banking Analyst in the Healthcare Group at Lazard Frères & Co. Michael graduated from the University of Pennsylvania as a member of the Vagelos Life Sciences & Management Program. He holds a B.S. in Economics from the Wharton School and a B.A. in Biology from the College of Arts and Sciences.

Edward J. Cook
CCO and VP of Legal Affairs

Edward Cook, CCO

Edward Cook joined Consonance in February 2016 as the Chief Compliance Officer. Prior to joining Consonance, Ed served as the CCO to Solar Capital Partners, Broadmark Asset Management and CM Investment Partners while working for Alaric Compliance Services from 2007 until joining Consonance. From 2004 to 2007, Ed worked at the Department of Homeland Security where he was Counsel to the head of Immigration and Customs Enforcement. He served in the United States Navy in the Judge Advocate General’s Corps, on active duty and in the Reserves, for over twenty years, having most recently held the rank of Commander. He began his career at the law firm of Cahill Gordon and Reindel, where his practice included securities litigation for a number of prominent financial services industry clients. Ed is admitted to practice law in New York. He holds an AB from the College of William and Mary and a JD from the University of Virginia School of Law.

Mary Sobon
VP of Finance

Mary Sobon – VP of Finance

Mary Sobon joined Consonance Capital in 2016. From May 2011 through 2016, Mary was an Associate Director at SS&C Globe Op responsible for accounting, reporting and fund services for various private equity funds. Prior to joining SS&C Globe Op, she was a manager at PricewaterhouseCoopers in the audit services group focusing on large public companies and private equity funds. Mary is a Certified Public Accountant and holds a BS in Accounting and an MBA both from Fairfield University.

Charles, G. Berg
Former CEO, Oxford Health Plans

Chuck Berg is a member of the Consonance Capital Partners Operating Council. Chuck serves on the board of DaVita HealthCare Partners, a leading provider of dialysis services for patients suffering from chronic kidney failure and the country's largest operator of medical groups and physician networks. Chuck served on the board of directors of WellCare Health Plans, Inc., a provider of managed care services for government-sponsored healthcare programs. Chuck served as executive chairman and as a member of the board from 2008 to 2010. Chuck became non-executive chairman of the board of directors of WellCare in 2011. From 1998 to 2004, Chuck held various executive positions with Oxford Health Plans, Inc. which included chief executive officer from 2002 to 2004 when Oxford was acquired by UnitedHealth Group, president and chief operating officer from 2001 to 2002 and executive vice president, medical delivery from 1998 to 2001. From 2004 to 2006, Chuck served as an executive of UnitedHealth Group and was primarily responsible for integrating the Oxford business. Chuck received his BA in political science from Macalester College and his JD from Georgetown University Law Center.

Carol J. Burt
Former SVP, WellPoint

Carol Burt is a member of the Consonance Capital Partners Operating Council. Carol is a principal of Burt-Hilliard Investments, a private investment and consulting service to the healthcare industry. Carol previously served as a member of the executive team that built WellPoint, Inc. from a single state Blue Cross plan to the country’s leading health benefits company. At her retirement, WellPoint had revenues of $61 billion, market capitalization of $50 billion and served 34.8 million members in all 50 states. Most recently, Carol served as Senior Vice President, Corporate Finance and Development. During her ten-year tenure from 1997 to 2007, Carol was responsible for, among other things, mergers and acquisitions, corporate strategy, strategic investments, capital planning and allocation, treasury and investment functions, and real estate management. She also oversaw WellPoint’s financial planning and analysis, forecasting and budgeting and business information services. In addition, WellPoint’s financial services and international insurance business units reported to her. Carol serves on the board of directors of WellCare Health Plans, Inc., a provider of managed care services for government-sponsored healthcare programs, Envision Healthcare, a provider of emergency medical transportation and outsourced facility-based physician services, and ResMed, a developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-disordered breathing and other respiratory disorders. Carol received her BBA in finance with a minor in accounting from the University of Houston.

Patrick B. Cline
CEO, Lightbeam Health Solutions, Inc.

Patrick Cline is a member of the Consonance Capital Partners Operating Council. Mr. Cline presently serves as CEO of Lightbeam Health Solutions, a population health technology and analytics company. He also serves on the boards of Conversio Health, Net Health and Frates Benefit Administrators. Mr. Cline founded NextGen Healthcare (NextGen), a leading provider of electronic health record, practice management, revenue cycle management technology and services. After the sale of NextGen to Quality Systems Inc. (NASDAQ: QSII), Mr. Cline stayed on as the company’s President. Based on NextGen's success, Quality Systems represented one of the most impressive growth stories on Wall Street. As Quality System's market cap approached three billion dollars in 2011, Mr. Cline retired from his role as President and Chief Strategy Officer. Mr. Cline started his career in healthcare IT as a software developer in 1980.

Leeba Lessin
Former CEO and President, CareMore Health System

Ms. Leeba Lessin is an Operating Council Member of Consonance Capital Partners. Ms. Lessin served as Chief Executive Officer and President of CareMore Health System until April 15, 2016 and currently continues in a consulting role. She has over 18 years of experience in the healthcare and managed care industries. Other roles include Executive Vice President of Medicare Programs at WellPoint Inc (now Anthem) and various positions at PacifiCare Health Systems, including President/Southern California, President/Northern California, President/Northwest and Vice President Provider Strategies. Prior to joining PacifiCare in 1995, she served as the Chief Executive Officer and President of Monarch Health Systems, a managed care delivery system operating in California's central coast region. In 2002, she formed Lessin Management Advisors, which provides consultation and strategic project management for companies in the healthcare industry. Ms. Lessin received a BA degree from Westmont College in Santa Barbara and an MBA from the University of Washington. She is a Board Member of The National Committee on Quality Assurance (NCQA) and supports liberal arts education through roles as a member of the Board of Advisors of Westmont College and the President's Council of Whittier College.

Arnold Chavkin
CIO, Pine Brook Road Partners

Arnie Chavkin is a member and Chairman of the Consonance Capital Partners Senior Advisory Board. Arnie worked closely with the Consonance Capital Partners Co-Founders during his 17 year tenure at JPMP. Currently, Arnie is a Managing Director and Chief Investment Officer at Pine Brook Road Partners, LLC ("Pine Brook"), a private equity firm focused on the financial services and energy sectors. Prior to Pine Brook, he worked at JPMP, where he was the Chief Investment Officer from 2001 to 2006. Prior to joining JPMP in 1990, Arnie was one of the first members of Chemical Bank’s Merchant Banking Group and its Corporate Finance Group, specializing in mergers and acquisitions and private placements for the energy industry. Earlier in his career, he held positions at Freeport McMoRan, Gulf and Western Industries, and Arthur Young & Company. Arnie is a member of the Columbia College Board of Visitors and the Columbia Business School Board of Overseers. Arnie is a Certified Public Accountant and received his BA and MBA degrees from Columbia University.

Sundeep Bhan
CEO, Medivo

Sundeep Bhan is a member of the Consonance Capital Partners Senior Advisory Board. Sundeep is currently the Chief Executive Officer of Medivo, a patient health monitoring company. Mr. Bhan has over 15 years of leadership experience with building teams, developing talent, and successfully growing, managing and selling businesses in healthcare marketing and technology. Prior to Medivo, Sundeep was the Chief Executive Officer and co-founder of Medsite, Inc. (sold to WebMD in 2006). He established Medsite as a leader in online pharmaceutical marketing and services by building an extensive online community of health care professionals, including over 400,000 U.S. physicians. After the sale of Medsite to WebMD, he worked on integration, new product development, and corporate strategy at WebMD. Sundeep received his BA from the Annenberg School of Communications at the University of Pennsylvania, with a concentration in business from the Wharton School of Business.

Vickie Capps
Former CFO, DJO Global

Vickie Capps is a member of the Consonance Capital Partners Senior Advisory Board. Vickie was the Executive Vice President, Chief Financial Officer and Treasurer of DJO Global, Inc. from 2007 to 2013. She was appointed to this position at the time of the 2007 merger of Blackstone Capital Partners’ ReAble Therapeutics and DJO Opco (formerly DJO Incorporated), a transaction that took the company private. From 2002 to 2007, Vickie served as the Executive Vice President, Chief Financial Officer and Treasurer of DJO Opco. Over Vickie's tenure with DJO she led over ten acquisitions and helped drive DJO’s revenues from $183 million in 2002 to $1.1 billion in 2011, reflecting a CAGR of over 20%. During her time with DJO, Vickie oversaw the company’s financial accounting, strategic financing, investor relations, business development, and information technology functions. From 2001 until 2002, Vickie was employed by AirFiber, a privately held provider of broadband wireless solutions, where she served as Senior Vice President, Finance and Administration and Chief Financial Officer. From 1999 to 2001, Vickie served as Vice President of Finance and Administration and Chief Financial Officer for Maxwell Technologies, Inc., a publicly traded technology company. From 1992 to 1999, Vickie served in various positions, including Chief Financial Officer, with Wavetek Wandel Goltermann, Inc., a multinational communications equipment company. Vickie also served as a senior audit and accounting professional for Ernst & Young, LLP from 1982 to 1992. Vickie served as a member of the board of directors of SenoRx, Inc. prior to its acquisition by C.R. Bard, Inc. in July 2010. Vickie is a California Certified Public Accountant. Vickie received her BS in business administration and accounting from San Diego State University.

Mark Lachs
Director of Geriatrics, New York Presbyterian Health System

Mark Lachs is a member of the Consonance Capital Partners Senior Advisory Board. Both a practicing internist-geriatrician and an internationally recognized physician-scientist in the field of aging, Mark is Director of Geriatrics for the New York Presbyterian Health Care System and The Irene and Roy Psaty Distinguished Professor of Medicine at Weill Cornell Medical College. Mark’s research interests include care of the frail older adult, chronic disease management, and the organization and financing of health care. His many honors include a National Institutes of Aging Academic Leadership Award, an American College of Physicians Teaching and Research Scholarship, and the Carter Burden Humanitarian Award in Aging. He has testified before the US Senate Committee on Aging, was a delegate to the White House Conference on Aging in 2006, and has served as a consultant to the World Health Organization. He is a principal in L3G Medtrics, an investor and incubator of early stage companies in the field of aging. Mark received his BA from the University of Pennsylvania, his MD from New York University, and his MPH in Chronic Disease Epidemiology from Yale where he was a Robert Wood Johnson Clinical Scholar. He completed a residency in Internal Medicine at the Hospital of the University of Pennsylvania and is Board Certified in both Internal Medicine and Geriatrics by the American Board of Internal Medicine.

Arthur Rubenstein
Former EVP UPenn Health System

Arthur Rubenstein, MBBCh is a member of the Consonance Capital Partners Senior Advisory Board. Arthur is an internationally-prominent endocrinologist recognized for clinical expertise and groundbreaking research in diabetes. From 2001 to 2011, Arthur was the Executive Vice President of the University of Pennsylvania Health System and the Dean of the Raymond and Ruth Perelman School of Medicine, where he is currently a Professor. Together, these entities make up Penn Medicine, a $3.6 billion enterprise, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Previously, Arthur served as Dean of Mount Sinai School of Medicine, where he was the Gustave L. Levy Distinguished Professor. Earlier, he was the Lowell T. Coggeshall Distinguished Service Professor of Medical Sciences and Chairman of the Department of Medicine at the University of Chicago Pritzker School of Medicine. Arthur served in numerous professional leadership positions throughout his career, including President of the Association of Professors of Medicine, President of the Association of American Physicians, President of the Central Society for Clinical Research, Chairman of the American Board of Internal Medicine, Chairman of the Board of the Association of Academic Health Centers, Chair of the National Diabetes Advisory Board, and member of the Advisory Council of the National Institute of Diabetes and Digestive and Kidney Diseases. Arthur has authored numerous publications and served on several editorial boards. Born in South Africa, Arthur received his medical degree from the University of the Witwatersrand in Johannesburg. In 2001, he was honored by his alma mater when an honorary degree, Doctor of Science in Medicine, was conferred upon him. He is a Fellow of the College of Medicine of South Africa and of the Royal College of Physicians of London; a Master of the American College of Physicians; American Academy of Arts and Sciences; and a member of the Institute of Medicine of the National Academy of Sciences.

Brent Turner
President, Acadia Healthcare

Brent Turner is a member of the Consonance Capital Partners Senior Advisory Board. Brent joined Acadia Healthcare, a national operator of behavioral health facilities, in February 2011 as Co-President and became President of Acadia in April 2012. Previously, Brent served as the Executive Vice President, Finance and Administration of Psychiatric Solutions, Inc. (“PSI”), an owner and operator of psychiatric hospitals, from August 2005 to November 2010 and as the Vice President, Treasurer and Investor Relations of PSI from February 2003 to August 2005. From late 2008 through 2010, Brent also served as a Division President of PSI overseeing facilities in Texas, Illinois and Minnesota. PSI grew from $114 million to $1.8 billion in revenue between 2002 and 2009. In 2010, Psychiatric Solutions was sold to Universal Health Services for $3.1 billion. From 1996 to 2001, Brent was employed by Corrections Corporation of America, a private prison operator, serving as Treasurer from 1998 to 2001. Brent received his BA in economics from Vanderbilt University and also received his MBA from the Owen Graduate School of Management at Vanderbilt University.

R. Blane Walter
Vice Chairman & Former CEO, InVentiv Health

Blane Walter is a member of the Consonance Capital Partners Senior Advisory Board. Blane presently serves as Vice Chairman of InVentiv Health and is a Partner at Talisman Capital Partners. Blane was the founder of inChord Communications, Inc., which he built into the largest independently-owned, healthcare communications company in the world. In 2005, inChord was acquired by Ventiv Health, the largest provider of outsourced sales and clinical services serving the pharmaceutical industry to create inVentiv Health. In 2008, Blane became CEO of the combined public company. Through organic growth and more than 20 acquisitions, inVentiv Health became the leading provider of outsourced product development and commercialization services to the global pharmaceutical and life sciences industries. inVentiv's client roster consists of more than 350 leading pharmaceutical, biotech, life sciences and healthcare payer companies. In 2010, Blane led the successful $1.2 billion buyout of inVentiv Health by Thomas H. Lee Partners. Prior to joining inChord, Blane worked as a Financial Analyst in New York City for Smith Barney in mergers and acquisitions specialty group. Blane received his BS in marketing and finance from Boston College.